Dr Charles Zheng

Dr Charles Zheng

Dr Charles Zheng is an Associate Director of Global Epidemiology at AbbVie, where he spearheads the Real-World Evidence (RWE) strategy across the JAPAC region.

In his current role, Dr Zheng focuses on strategic partnerships that maximize the utility of real-world evidence (RWE) to support product launches, R&D priorities, and post-marketing safety profiles.

Prior to joining AbbVie, he held regional and country-level Market Access roles at Roche Diagnostics APAC and GSK, respectively, where he led market access initiatives, health economic modeling, and pricing negotiations. His industry expertise is grounded in his time as a Senior Epidemiologist at Singapore Clinical Research Institute (SCRI), where he collaborated with public hospitals to design and execute multi-center RWE studies.

A dedicated contributor to the scientific community, Dr Zheng has co-authored over 30 articles in peer-reviewed journals.